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PERSPECTIVE
Activation of β2 adrenergic receptors 
promotes adult hippocampal 
neurogenesis
The subgranular zone (SGZ) of the hippocampal dentate gyrus 
is one of the few central nervous system regions where genera-
tion of adult born neurons occurs physiologically. This process, 
referred to as adult hippocampal neurogenesis (ahN), relies on 
the presence of neural progenitor cells (NPC) in the SGZ neu-
rogenic niche. NPC, in response to appropriate cues and sig-
nals, give rise to neuroblasts migrating to the granular cell layer 
(GCL) where they mature into neurons functionally integrated 
into the hippocampal circuit (Toda et al., 2019). Although the 
functional role of adult born hippocampal neurons is not fully 
understood, a vast array of experimental evidence suggest that 
these cells are involved in crucial hippocampal-dependent func-
tions like specific types of learning and memory and emotional 
responses (Toda et al., 2019). Intriguingly, deregulated ahN has 
been associated with several neurodegenerative and neuropsy-
chiatric diseases. Major depression, in particular, is one of the 
disorders where dysregulated ahN has been more extensively 
studied (Boldrini et al., 2012; Bortolotto et al., 2014).
In recent years, our laboratory has been actively searching for 
novel modulators of ahN with potential therapeutic relevance. 
We could demonstrate that several drugs commonly utilized in 
the clinical settings are endowed with the ability of promoting 
or inhibiting ahN in vitro and/or in vivo (Bortolotto et al., 2014; 
Bortolotto and Grilli, 2017). Although at the preclinical level, 
our results suggested novel mechanisms of action and therapeu-
tic indications for such drugs. 
An intriguing and still undervalued aspect of ahN is its mod-
ulation by endogenous neurotransmitters. As an example, the 
SGZ niche receives a dense monoaminergic innervation (Toda 
et al., 2019). These findings are particularly interesting from a 
pharmacological perspective, since several clinically relevant 
drugs affect monoaminergic neurotransmission either directly 
or indirectly. Several lines of research provided evidence that 
classical antidepressants are positive modulators of ahN in hu-
man and rodent hippocampus. Moreover it has been proposed 
that the proneurogenic activity of antidepressants may, at least 
in part, contribute to the therapeutic effects of these drugs (Bol-
drini et al., 2012). While the role of serotonin receptor subtypes 
in ahN modulation has been extensively investigated both in 
vitro and in vivo, less is known about the role of adrenergic 
receptor (AR) in the regulation of ahN. This probably reflects 
the more extensive clinical use of Selective Serotonin Reuptake 
Inhibitors rather than antidepressants acting on noradrenergic 
transmission in depressed patients. Despite that, a particularly 
rich noradrenergic innervation of the SGZ originates in the 
locus coeruleus (LC), and there is also evidence that LC norad-
renergic boutons make direct contact with NPC (Sara, 2009). 
Although β-ARs are of particular importance in several NA-me-
diated effects in the CNS, the specific contribution of distinct 
subtypes (β1, β2, β3) remains to be fully understood. Based on 
these premises, we recently dissected the role of distinct β-AR 
subtypes, all functionally expressed by adult hippocampal NPC 
(ahNPC), in the modulation of ahN. Physiologically relevant 
noradrenaline concentrations significantly increased ahNPC 
proliferation rate in vitro, an effect which appeared to be medi-
ated by β1-AR engagement (Bortolotto et al., 2019). Conversely, 
β2-AR subtype activation mediated noradrenaline effects on 
neuronal differentiation of adult hNPC. The contribution of β2-
AR to in vitro neurogenesis was confirmed by the fact that nor-
adrenaline and β2-AR agonists like salmeterol and formoterol 
were ineffective on neuronal differentiation in hNPC primary 
cultures isolated from β2-AR
–/– mice. Of note, β3-AR stimulation 
could promote neurogenesis in β2-AR
–/– NPC cultures, con-
firming also this receptor subtype as positive modulator of ahN 
(Bortolotto et al., 2019). These in vitro observations prompted 
us to use β2-AR agonists, molecules employed in the clinical 
setting as antiasthmatic drugs, as pharmacological tools in an 
in vivo study aimed at evaluating their activity as neurogenesis 
enhancers. For such purpose we selected salmeterol, a long-act-
ing β2-AR which crosses the blood-brain barrier. The drug, 
chronically (21 days) administered at a clinically relevant dose, 
significantly promoted neurogenesis in the adult murine hippo-
campus, as revealed by a remarkable increase in the number of 
BrdU+/NeuN+ newly generated neurons (Bortolotto et al., 2019). 
Of note, the number of total hippocampal BrdU+ cells was not 
different between vehicle- and salmeterol-treated mice, sug-
gesting that β2-AR agonist administration had little/no effect on 
cell survival and/or proliferation in the adult neurogenic niche. 
This finding is in line with the in vitro observation that β1-AR, 
rather than the β2-AR subtype, is involved in the modulation of 
NPC proliferation. The proneurogenic effect of chronic salme-
terol administration also correlated with a significant increase 
in the number of doublecortin (DCX) immunolabelled cells in 
the GCL of salmeterol-treated compared to vehicle-treated an-
imals (Bortolotto et al., 2019). DCX is a microtubule associated 
protein expressed by immature neurons in the adult dentate 
gyrus, and it is commonly utilized as a marker of adult-born 
neuroblasts (Dellarole and Grilli, 2008). In the GCL, the radially 
oriented DCX+ cell subpopulation is considered to represent a 
more advanced stage of maturation and migration compared to 
the cells which are tangentially oriented. Interestingly, in parallel 
with the increased number of DCX+ cells, in salmeterol-treated 
mice we also observed a significant increase in the percentage 
of radially–compared to tangentially-oriented neuroblasts. The 
DCX marker is widely used for morphometric analysis of the 
dendritic arborizations of adult-born hippocampal neuroblasts, 
whose complexity is also a maturation index. Our analysis re-
vealed a positive effect of chronic salmeterol administration 
on DCX+ dendritic complexity and length, compared to vehi-
cle-treated animals (Bortolotto et al., 2019). Altogether, our data 
suggested the idea that chronic salmeterol treatment increased 
hippocampal neuroplasticity by promoting both adult born 
neuroblast maturation and neurogenesis. 
We believe that the findings of a novel pharmacological activ-
ity for salmeterol are worth of being further pursued in future 
studies. The noradrenergic neurotransmission plays key reg-
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ulatory roles in a variety of physiological processes, including 
specific cognitive aspects which can be functionally correlated 
with ahN (Sara, 2009). Based on in vitro data, we suggest that 
adult hippocampal NPC and/or their DCX+ progeny are cellular 
targets for the proneurogenic in vivo effects of salmeterol. Of 
course, at this stage of knowledge, we cannot exclude the possi-
bility that other cell types may also contribute to mediate, either 
directly or indirectly, the proneurogenic effects of salmeterol. 
For example, β2-AR stimulation in astrocytes, which express 
this receptor subtype, may result in modulation of expression 
and/or release of trophic factors and/or other soluble molecules 
which, in turn, may promote hippocampal neuroblasts matura-
tion and neurogenesis (Cvijetic et al., 2017; Spampinato et al., 
2019). 
   An unexpected finding of the chronic salmeterol study in 
adult mice was that the proneurogenic effects of salmeterol 
administration appeared to be restricted to ventral hippocam-
pus (vHp). Region-specificity of salmeterol effects is a quite 
interesting observation since anatomical segregation along 
hippocampal dorso-ventral axis is an established concept (Grilli 
et al., 1988). Indeed, while dorsal hippocampus mainly receives 
inputs from cortical areas, vHp is more connected with sub-
cortical structures, such as amygdala and the hypothalamic-pi-
tuitary-adrenal axis. Dorsal and ventral hippocampus are also 
segregated functionally: dorsal hippocampus has been correlat-
ed with cognitive functions such as spatial navigation, memory 
and learning, while the vHp with mood regulation, emotional 
behavior and buffering stress (Tanti and Belzung, 2013). 
Chronic stress preferentially elicits deleterious effects on 
vHp neurogenesis and chronic antidepressant drugs have been 
shown to preferentially increase neurogenesis in rodent vHp 
(Tanti and Belzung, 2013). Moreover studies in depressed pa-
tients showed prominent effects of monoaminergic antidepres-
sants in the anterior part of the hippocampus, the human cor-
relate of rodent vHp (Boldrini et al., 2012). In such context, our 
demonstration that hippocampal neuroplasticity and neurogen-
esis induced by administration of chronic salmeterol occurs in 
the vHp of naïve adult mice, imposes that behavioural correlates 
of these effects should be further investigated. Specifically, the 
effects of salmeterol in animal models of stress-induced depres-
sive-like behavior could be tested. Additionally, the possibility 
that salmeterol and/or β2-AR agonists that pass the blood-brain 
barrier may enhance antidepressant effects exists and should be 
evaluated. In light of the fact that a third of patients suffering 
major depression do not satisfactorily respond or are resistant 
to antidepressant treatment, these observations certainly de-
serve further attention. Last but not least, ahN is also impaired 
in aging and in neurodegenerative diseases. As an example, 
Alzheimer’s disease has been recently associated with a dramat-
ic reduction in the number of adult born hippocampal neu-
roblasts, suggesting their degeneration in the disorder (More-
no-Jimenez et al., 2019). These observations suggest the need of 
evaluating the potential of β2-AR agonists for preventing and/or 
attenuating the deterioration of hippocampal-associated func-
tions, including cognitive impairment and mood disturbancies, 
in Alzheimer’s disease and brain aging.  
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